Top Story

Early ART proves more beneficial than deferred treatment

Early ART proves more beneficial than deferred treatment
May 28, 2015

Results from the ongoing START trial suggest early initiation of ART significantly reduces the progression to AIDS and other serious illnesses.

Taken together with previous research demonstrating that ART lowers the risk for sexual transmission of HIV in serodiscordant couples, these findings appear to support guidelines in the United States recommending treatment for asymptomatic HIV patients regardless of CD4 count.

In the Journals

Infective endocarditis after TAVR associated with poor outcomes

May 28, 2015
Among patients undergoing transcatheter aortic valve replacement, those who developed infective endocarditis had a high rate of mortality and other poor outcomes…

Harvoni added benefit for patients with HCV/HIV coinfection

May 28, 2015
In a manufacturer dossier assessment conducted by the Institute for Quality and Efficiency in Health Care in Germany, Harvoni was deemed to have an added benefit for…

CMS proposes updated Medicaid, CHIP-managed care regulations

May 28, 2015
CMS recently proposed a rule to update managed care regulations for Medicaid and the Children’s Health Insurance Program, according to a press release.The…
Keiji Fukuda

World Health Assembly backs plan to reduce antimicrobial resistance

May 28, 2015
The World Health Assembly, which recently concluded its annual meeting in Geneva, approved a resolution this week to address antimicrobial resistance worldwide…
More News Headlines »
CME
HCV VOICE

HCV VOICE II: Optimizing Virological Outcomes with Integrated HCV Education

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
Meeting News Coverage Video
VIDEO: C-SURFER: Patients with kidney disease, HCV achieve high rates of SVR

VIDEO: C-SURFER: Patients with kidney disease, HCV achieve high rates of SVR

April 25, 2015
VIENNA — Howard Monsour Jr., MD, chief of hepatology, Houston Methodist Hospital, Texas, discussed results of…
More »
CME
Infectious Disease Case Consults

The Patient at Risk for HIV Infection

No commercial support for this activity.

This CME activity will focus on the utilization of PrEP in patients at risk for developing HIV infection supplemented…
More »